Founded
31 Dec 2001
Address
DecImmune Therapeutics Inc
Cambridge, MA
United States
Website
VCID: 130501
Profile
Corporate information
Registration country
Registration country
Investment activity status
Active investor
Company type
Developer of antibodies to reduce tissue damage and improve ventricular function associated with myocardial infarctionFunding
Funding rounds
Investor | Profile | Country | Notes | |
---|---|---|---|---|
Healthcare Ventures LLC | Venture capital firm focused on life sciences companies in pre-clinical and early clinical stage. | United States |
Cap Table
Current and past shareholders
Investor | Contacts | Round | |
---|---|---|---|
Astellas Venture Capital LLC |
N/A | ||
Astellas Venture Management LLC |
N/A | ||
Healthcare Ventures LLC Venture capital firm focused on life sciences companies in pre-clinical and early clinical stage. |
+1 (617) 252-4343 |
N/A |